Table of Contents

Parkin Mediates Neuroprotection through Activation of IκB Kinase/Nuclear Factor-κB Signaling

  1. Konstanze F. Winklhofer1
  1. 1Department of Biochemistry, Adolf-Butenandt-Institute, D-80336 Munich, Germany,
  2. 2Departments of Pharmacy, Pharmaceutical Biology-Biotechnology, and
  3. 3Physiological Genomics, Institute of Physiology, Ludwig-Maximilians-University, D-80336 Munich, Germany,
  4. 4Gesellschaft für Strahlenforschung–Research Center for Environment and Health, Institute of Toxicology, D-85764 Neuherberg, Germany, and
  5. 5Institute of Neurological Sciences, Department of Neurology, Tottori University, Yonago, Tottori 683-8504, Japan
  1. Correspondence should be addressed to Konstanze F. Winklhofer, Schillerstrasse 44, D-80336 Munich, Germany. konstanze.winklhofer{at}med.uni-muenchen.de

Abstract

Mutations in the parkin gene are a major cause of autosomal recessive Parkinson's disease. Here we show that the E3 ubiquitin ligase parkin activates signaling through the IκB kinase (IKK)/nuclear factor κB (NF-κB) pathway. Our analysis revealed that activation of this signaling cascade is causally linked to the neuroprotective potential of parkin. Inhibition of NF-κB activation by an IκB super-repressor or a kinase-inactive IKKβ interferes with the neuroprotective activity of parkin. Furthermore, pathogenic parkin mutants with an impaired neuroprotective capacity show a reduced ability to stimulate NF-κB-dependent transcription. Finally, we present evidence that parkin interacts with and promotes degradation-independent ubiquitylation of IKKγ/NEMO (NF-κB essential modifier) and TRAF2 [TNF (tumor necrosis factor) receptor-associated factor 2], two critical components of the NF-κB pathway. Thus, our results support a direct link between the neuroprotective activity of parkin and ubiquitin signaling in the IKK/NF-κB pathway.